Aptar Pharmaleadsthe organization of the 7th Innovative Drug Delivery Solutions Symposium 2018, Hangzhou, China

Aptar Pharma, a leading drug delivery systems provider, is proud to announce its leading role in the organization of the forthcoming 7th Innovative Drug Delivery Solutions Symposium (IDDS). The biennial conference is to be held this year at the SORL Hotel Hangzhou, Hangzhou, Chinafrom March 28-30, 2018.

IDDS provides pharmaceutical researchers with a global platform to collaborate and productively address pharma trends. This symposium will bring together experts to engage in the latest developments in industry regulations, drug delivery technology and formulation advancements.

Aptar Pharma will sponsor a boothat IDDS, exhibiting its diverse portfolio of drug delivery solutions andshowcasing their latest innovations.

Four of Aptar Pharma’s experts will be guest speakers during the symposium, sharing insights into the company’s innovative drug delivery developments and solutions for the wider pharmaceutical market.

• GuillaumeBrouet, President Global Market Development Prescription Division, will present twoconference talks at the symposium:

                 – “FDA Regulatory Affairs”will discuss regulatory trends and combination products, and will take place on March 28 at 14:00.
                 – “Global Nasal Drug Delivery Trends and Device Design” will take placeon March 29 at 13:15.

• Guenter Nadler, Director Business Development – Consumer Health, will present “Nasal Saline Global Trends”on March 29 at 15:20. His talk will discuss the global trends and developments of nasal saline, and share insights in relation to formulation and device developments.
• Cory Wu, Senior Technical Manager,will present the topic of “Customized Healthy Drug Delivery Devices”on March 30 at 08:30. He will discuss the benefits of customized devices and how customers can work with Aptar Pharma to create bespoke drug delivery designs.
• Sai Shankar, Director Business Development – Connected Devices, will present “Driving Better Patient Outcomes with Connectivity”on March 30 at 10:00. This talk will focus on connected technologies in inhalationand integrated connected pMDIs.

GuillaumeBrouet, President Global Market Development Prescription Division at Aptar Pharma comments, “Aptar Pharma is delighted to be a co-organizer of this year’s event. IDDS is a well-respected and successful symposium for the global pharmaceutical market, bringing together pharma experts from across the industry. I am pleased to have the opportunity to host two talks at IDDS and look forward to sharing my expertise there”.

About Aptar Pharma
Aptar Pharma is part of AptarGroup, Inc , a leading global supplier of a broad range of innovative dispensing and sealing solutions for the beauty, personal care, home care, prescription drug, consumer health care, injectables, food and beverage markets. AptarGroup is headquartered in Crystal Lake, Illinois, with manufacturing facilities in North America, Europe, Asia and South America. For more information, visit aptar.com/pharma.